Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Bullboard Posts
Post by Nohandledzepon Oct 20, 2012 6:04pm
341 Views
Post# 20506789

Immunocidin - 88% Cure Rate after 2 Years?

Immunocidin - 88% Cure Rate after 2 Years?

Did somebody post the other day, Beech,  Stooge or RG  perhaps, that Bioniche was permitted to use Regressin trial data for the Immunocidin submission.

 

If I recall correctly, Regressin demonstrated an 88% cure rate after two years, with limited to no side effects. If this is in fact true, and I have every reason to believe that it is, that 1% market share seems a tad limp... Particularly when no special skills or equipment  are required to sell and or administer the drug, it will be available to any vet as a treatment option and the chemo/radiation based competition have a fraction of the CR, with horrible side effects.

 

As usual, something seems a bit odd. 1% market share...88% Cure Rate, No SideEffects, Easy to Administer?

Bullboard Posts